Matthew Reiser Patton
4Patents
2h-index
20Co-inventors
40Inventor score
Filing activity: Sep 7, 2018 → Jul 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11198713B2 | Agents modulating beta-catenin functions and methods thereof | Chemistry; Metallurgy | 3 | Active |
| US11767322B2 | Triazolopyridinyl compounds as kinase inhibitors | Human Necessities | 2 | Active |
| US12110290B2 | Triazolopyridinyl compounds as kinase inhibitors | Human Necessities | 0 | Active |
| US11834482B2 | Agents modulating beta-catenin functions and methods thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.